Custom Search

Health - Update.Pk

Categories
Virtual Web Air Quality Bohra Calendar Costume Jewelry Pearl bracelet Baitullah Forex Demo


Explore the categories so you can find more about your search.

Categorie > Pharma Industry

2010 BIO International Convention Expected To Bring More Than $25 Million To Chicago

Categorie : Pharma Industry
The Biotechnology Industry Organization announced that the 2010 BIO International Convention is expected to contribute more than $25 million to the local economy, according to estimates from the Chicago Convention and Tourism Bureau. The BIO International Convention returns to Chicago May 3-6 and is ...

read more The Biotechnology Industry Organization announced that the 2010 BIO International Convention is expected to contribute more than $25 million to the local economy, according to estimates from the Chicago Convention and Tourism Bureau. The BIO International Convention returns to Chicago May 3-6 and is read more Sat Mar 2010 Sat Mar 2010

FDA Approves Name Change For Heartburn Drug Kapidex

Categorie : Pharma Industry
The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex (dexlansoprazole) to avoid confusion with two other medications - Casodex and Kadian. Effective in late April 2010, Takeda Pharmaceuticals North America Inc. will market Kapidex under the new name Dexilan ...

read more The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex (dexlansoprazole) to avoid confusion with two other medications - Casodex and Kadian. Effective in late April 2010, Takeda Pharmaceuticals North America Inc. will market Kapidex under the new name Dexilan read more Sat Mar 2010 Sat Mar 2010

Supelco(R) Introduces Breakthrough In Bioseparations Performance -- Ascentis(R) Express ES-C18 HPLC Columns

Categorie : Pharma Industry
Supelco, a division of Sigma-Aldrich® (Nasdaq: SIAL), announced the launch of Ascentis Express Peptide ES-C18, a high-speed, high-performance liquid chromatography (HPLC) column based on a new 160 angstrom Fused-Core™ particle design... ...

read more Supelco, a division of Sigma-Aldrich® (Nasdaq: SIAL), announced the launch of Ascentis Express Peptide ES-C18, a high-speed, high-performance liquid chromatography (HPLC) column based on a new 160 angstrom Fused-Core™ particle design... read more Fri Mar 2010 Fri Mar 2010

BIO Announces New Networking And Collaboration Forum At 2010 BIO International Convention

Categorie : Pharma Industry
The 2010 BIO International Convention will feature the first-ever BIOPark, a hub focused on fostering networking and collaboration among academics, licensing professionals, incubator services, and early-stage companies, announced the Biotechnology Industry Organization (BIO) today... ...

read more The 2010 BIO International Convention will feature the first-ever BIOPark, a hub focused on fostering networking and collaboration among academics, licensing professionals, incubator services, and early-stage companies, announced the Biotechnology Industry Organization (BIO)  today... read more Fri Mar 2010 Fri Mar 2010

Drugmakers' Business Practices Draw Scrutiny

Categorie : Pharma Industry
Three top California Medicaid officials in charge of pharmacy issues failed to disclose trips paid for by drug-industry funded business groups, California Watch/San Francisco Chronicle reports. Officials who are directly involved in setting drug policy and negotiating payments took about 12 trips p ...

read more  Three top California Medicaid officials in charge of pharmacy issues failed to disclose trips paid for by drug-industry funded business groups, California Watch/San Francisco Chronicle reports. Officials who are directly involved in setting drug policy and negotiating payments took about 12 trips p read more Fri Mar 2010 Fri Mar 2010

Activists And Lobbyists Ramp Up Efforts In Possible Final Health Care Push

Categorie : Pharma Industry
Politico: "In the absence of clear next steps, outside groups have stepped in to beat the drum, keeping time while the leadership meets behind closed doors to write the next movement. ... Progressive advocacy groups like Health Care for America Now and Families USA are organizing supporters a ...

read more        Politico: read more Fri Mar 2010 Fri Mar 2010

One-on-One Partnering Opens Today For The 2010 BIO International Convention Business Forum

Categorie : Pharma Industry
The Biotechnology Industry Organization announces that representatives of biotech and pharmaceutical companies, academic research institutions and licensing professionals, as well as investors attending the BIO International Convention Business Forum can now begin to request One-on-One business dev ...

read more The Biotechnology Industry Organization announces that representatives of biotech and pharmaceutical companies, academic research institutions and licensing professionals, as well as investors attending the BIO International Convention Business Forum  can now begin to request One-on-One business dev read more Fri Mar 2010 Fri Mar 2010

BIO Joins NORD In Supporting The Goals Of Rare Disease Day

Categorie : Pharma Industry
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement in observance of Rare Disease Day 2010. This event recognizes the profound need for more medical research and the unique partnership that exists between rare disease patients and researchers... ...

read more Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement in observance of Rare Disease Day 2010. This event recognizes the profound need for more medical research and the unique partnership that exists between rare disease patients and researchers... read more Fri Mar 2010 Fri Mar 2010

Cabazitaxel Increased Survival For Patients With Advanced Hormone-Refractory Prostate Cancer

Categorie : Pharma Industry
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refracto ...

read more Sanofi-aventis (EURONEXT: SAN and NYSE:  SNY) announced results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refracto read more Fri Mar 2010 Fri Mar 2010

BIO Welcomes EU Decision On Biotech Crops

Categorie : Pharma Industry
The Biotechnology Industry Organization (BIO) applauded today's announcement by the European Commission to authorize the cultivation of a biotech potato, as well as the commercialization of three varieties of biotech maize for food and feed uses and import and processing... ...

read more The Biotechnology Industry Organization (BIO) applauded today's announcement by the European Commission to authorize the cultivation of a biotech potato, as well as the commercialization of three varieties of biotech maize for food and feed uses and import and processing... read more Fri Mar 2010 Fri Mar 2010

75 Percent Of Drug Companies Formally Manage Investigator-Initiated Trials

Categorie : Pharma Industry
Investigator-initiated trials (IITs) provide companies with clinical data to expand scientific understanding of their drugs and reap a number of additional benefits. IIT management, however, can be challenging. Data collected by business intelligence firm Cutting Edge Information show that 75% of su ...

read more Investigator-initiated trials (IITs) provide companies with clinical data to expand scientific understanding of their drugs and reap a number of additional benefits. IIT management, however, can be challenging. Data collected by business intelligence firm Cutting Edge Information show that 75% of su read more Fri Mar 2010 Fri Mar 2010

Medtronic Named Among World's Most Innovative Companies By MIT Technology Review

Categorie : Pharma Industry
Medtronic, Inc. (NYSE: MDT) announced that it has been selected as one of Massachusetts Institute of Technology (MIT) Technology Review's 50 most innovative companies. Known as TR50, the first annual list includes companies that Technology Review believes have demonstrated superiority in inventing t ...

read more Medtronic, Inc. (NYSE: MDT) announced that it has been selected as one of Massachusetts Institute of Technology (MIT) Technology Review's 50 most innovative companies. Known as TR50, the first annual list includes companies that Technology Review believes have demonstrated superiority in inventing t read more Fri Mar 2010 Fri Mar 2010

BIO Proposes Second Wave Of Advanced Biofuel Commercialization Policy To Stimulate Job Creation

Categorie : Pharma Industry
Additional Congressional action is needed to follow through on the Obama administration's recently announced initiative to rapidly build an integrated value chain for the bioeconomy, create jobs and kick start economic growth. The Biotechnology Industry Organization (BIO) today released proposed pol ...

read more Additional Congressional action is needed to follow through on the Obama administration's recently announced initiative to rapidly build an integrated value chain for the bioeconomy, create jobs and kick start economic growth. The Biotechnology Industry Organization (BIO) today released proposed pol read more Wed Feb 2010 Wed Feb 2010

Launch Of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 Mg) In France For The Treatment Of Prostate Cancer

Categorie : Pharma Industry
Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by I ...

read more Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by I read more Wed Feb 2010 Wed Feb 2010

State Policy Developments: Iowa Seeks To Extend Birth Control Coverage; Minn. Eyes More Health Care For Poor; Miss. Drug Settlement

Categorie : Pharma Industry
BusinessWeek: "Mississippi will receive $18.5 million from drug maker Eli Lilly and Co. as part of a settlement over claims the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat, Attorney General Jim Hood said Thursday" (Byrd, 2/4)... ...

read more        BusinessWeek: read more Wed Feb 2010 Wed Feb 2010

Health Bill Stall Creates Uncertainty For Drug Makers

Categorie : Pharma Industry
"With the possible demise of health care legislation, getting back to business as usual may not be the best thing for the nation's drug makers," The New York Times reports... ...

read more read more Wed Feb 2010 Wed Feb 2010

Medical Breakthroughs With Biotechnology

Categorie : Pharma Industry
A recent article in the Scandia Journal reported that biotechnology is helping to improve our knowledge of many devastating illnesses, and has armed patients and their doctors with exciting new diagnostics and treatments to battle disease... ...

read more A recent article in the Scandia Journal reported that biotechnology is helping to improve our knowledge of many devastating illnesses, and has armed patients and their doctors with exciting new diagnostics and treatments to battle disease... read more Wed Feb 2010 Wed Feb 2010

APCER Pharma Announces That LPC Pharma Group To Outsource Pharmacovigilance/Drug Safety To APCER

Categorie : Pharma Industry
APCER Pharma announced that LPC Pharma Group is outsourcing its http://www.pharmacovigilance/drug safety operations to APCER. APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consu ...

read more APCER Pharma announced that LPC Pharma Group is outsourcing its http://www.pharmacovigilance/drug safety operations to APCER.  APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consu read more Wed Feb 2010 Wed Feb 2010

BIO Joins Stakeholders In Expressing Concerns With Efforts To Restrict Gene Patenting

Categorie : Pharma Industry
The Biotechnology Industry Organization (BIO) released a letter to Health and Human Services Secretary Kathleen Sebelius regarding the potentially harmful recommendations of the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) in its Report on Gene Patents and Licensing Practi ...

read more The Biotechnology Industry Organization (BIO) released a letter to Health and Human Services Secretary Kathleen Sebelius regarding the potentially harmful recommendations of the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) in its Report on Gene Patents and Licensing Practi read more Wed Feb 2010 Wed Feb 2010

State News: New York Governor Wants Regulation On Rx Gifts To Doctors And Other State News

Categorie : Pharma Industry
The Associated Press/CNBC reports that New York Gov. David Paterson is "proposing new, tougher prohibitions on pharmaceutical companies, restricting them from dispensing gifts and misleading production information to doctors while promoting the use of specific drugs." Nine states have similar ...

read more        The Associated Press/CNBC reports that New York Gov. David Paterson is read more Thu Jan 2010 Thu Jan 2010

1 | 2 | 3 | 4 next >>>
eHealth Guide NewsAbortionADHDAid / DisastersAlcohol / AddictionAllergyAlzheimer'sAnxietyArthritisAsthma / RespiratoryAutismBio-terrorism / TerrorismBiology / BiochemistryBipolarBird Flu / Avian FluBlood / HematologyBody AchesBones / OrthopaedicsBreast CancerCancer / OncologyCardiovascular / CardiologyCaregivers / HomecareCholesterolCJD / vCJD / Mad Cow DiseaseCleft PalateClinical Trials / Drug TrialsColorectal CancerComplementary Medicine / Alternative MedicineComplianceConferencesCosmetic Medicine / Plastic SurgeryCrohn'sCystic FibrosisDentistryDepressionDermatologyDiabetesDyslexiaEar, Nose and ThroatEndocrinologyEpilepsyErectile Dysfunction / Premature EjaculationEye Health / OptometryFertilityFlu / SARSGastroIntestinalGeneticsGoutHeadache / MigraineHealth Insurance / Medical InsuranceHearing / DeafnessHIV / AIDSHuntingtons DiseaseHypertensionImmune System / VaccinesInfectious Diseases / Bacteria / VirusesIrritable-Bowel SyndromeLiver Disease / HepatitisLung CancerLupusLymphoma / LeukemiaMedical DevicesMedical Malpractice / LitigationMedical StudentsMedicare / Medicaid / TricareMen's healthMental HealthMRI / PET / UltrasoundMRSA / Drug ResistanceMultiple SclerosisMuscular DystrophyNeurology / NeuroscienceNursingNutrition/AgricultureObesity / Weight Loss / FitnessPain / AnestheticsParkinson's DiseasePediatricsPharma IndustryPregnancyPrimary Care / General PracticeProstatePsychology / PsychiatryPublic HealthRadiology / Nuclear MedicineRehabilitationSchizophreniaSeniors / AgingSexual Health / STDsSleep / Sleep DisordersSmoking / Quit SmokingSports Medicine / FitnessStatinsStem Cell ResearchStroke / NeuroprotectionTransplants / Organ DonationsTropical DiseasesUrology / NephrologyVeterinaryWater Quality / Air QualityWomen's Health / OBGYNHealth PolicyHealth Jobs Listing